Consequence of Bisphosphonate on Dental Implant Success in Osteoporotic Females

Objective: To evaluate the effect of Bisphosphonate on Dental Implant failure rate in osteoporotic female patients. Patients and Method: Fifteen osteoporotic female patients underwent surgery to place 72 fixtures, in upper jaw, loaded completely within 4 months. Patients take Alendronate tablet 10 mg once daily for 8 months, 2 months preoperative and 6 months postoperative. Compares with healthy females underwent implant surgery too. Results: Six dental implants were failed at the time of second step surgery (Gingival Former Step), with no other complication faced by the patients whether related to drug used or to surgery. Three fixtures were failed in healthy females. Statistically no significant differences in the effect of bisphosphonate on dental implant failure. Discussion: Patients who take oral Bisphosphonate are no more at risk of implant failure than normal patients with no drug use. *Corresponding author: Rawaa Y Al-Rawee BDS, MSc, MOMSRCPS Glasgow (Ph.D.MaxFacs) Department of Oral and Maxillofacial Surgery Al-Salam Teaching Hospital Al-Sukar, Mosul, Iraq Tel: 009647726438648 E-mail: dr.rawarawi@yahoo.com Citation: Al-Rawee RY, Saeed AM, Tawfeeq BAG. Consequence of Bisphosphonate on Dental Implant Success in Osteoporotic Females. J Dents Dent Med. 2019 Mar;2(1):127 Copyright: © 2019 Al-Rawee RY, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 international License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. 1Department of Oral and Maxillofacial Surgery, Al-Salam Teaching Hospital, Mosul, Iraq 2Department of Oral and Maxillofacial Surgery, Al-Gemhoory Teaching Hospital, Mosul, Iraq Rawaa Y Al-Rawee1* Ali Mohammad Saeed2 Bashar Abdul-Ghani Tawfeeq1